Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis.
Atopic dermatitis (AD) is a widespread and difficult to treat allergic skin disease and is a tough challenge for healthcare. In this study, we investigated whether allergen-specific immunotherapy (ASIT) with a monomeric allergoid obtained by succinylation of ovalbumin (sOVA) is effective in a mouse...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0135070 |
| _version_ | 1819032660213760000 |
|---|---|
| author | Nadezda Shershakova Elena Bashkatova Alexander Babakhin Sergey Andreev Alexandra Nikonova Igor Shilovsky Oleg Kamyshnikov Andrey Buzuk Olga Elisyutina Elena Fedenko Musa Khaitov |
| author_facet | Nadezda Shershakova Elena Bashkatova Alexander Babakhin Sergey Andreev Alexandra Nikonova Igor Shilovsky Oleg Kamyshnikov Andrey Buzuk Olga Elisyutina Elena Fedenko Musa Khaitov |
| author_sort | Nadezda Shershakova |
| collection | DOAJ |
| description | Atopic dermatitis (AD) is a widespread and difficult to treat allergic skin disease and is a tough challenge for healthcare. In this study, we investigated whether allergen-specific immunotherapy (ASIT) with a monomeric allergoid obtained by succinylation of ovalbumin (sOVA) is effective in a mouse model of atopic dermatitis. An experimental model of AD was reproduced by epicutaneous sensitization with ovalbumin (OVA). ASIT was performed with subcutaneous (SC) administration of increasing doses of OVA or sOVA. The levels of anti-OVA antibodies, as well as cytokines, were detected by ELISA. Skin samples from patch areas were taken for histologic examination. ASIT with either OVA or sOVA resulted in a reduction of both the anti-OVA IgE level and the IgG1/IgG2a ratio. Moreover, ASIT with sOVA increased the IFN-γ level in supernatants after splenocyte stimulation with OVA. Histologic analysis of skin samples from the sites of allergen application showed that ASIT improved the histologic picture by decreasing allergic inflammation in comparison with untreated mice. These data suggest that ASIT with a succinylated allergen represents promising approach for the treatment of AD. |
| first_indexed | 2024-12-21T07:05:28Z |
| format | Article |
| id | doaj.art-6b43ea1f9a0a420c84bb82a32883ea9f |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-21T07:05:28Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-6b43ea1f9a0a420c84bb82a32883ea9f2022-12-21T19:12:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01108e013507010.1371/journal.pone.0135070Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis.Nadezda ShershakovaElena BashkatovaAlexander BabakhinSergey AndreevAlexandra NikonovaIgor ShilovskyOleg KamyshnikovAndrey BuzukOlga ElisyutinaElena FedenkoMusa KhaitovAtopic dermatitis (AD) is a widespread and difficult to treat allergic skin disease and is a tough challenge for healthcare. In this study, we investigated whether allergen-specific immunotherapy (ASIT) with a monomeric allergoid obtained by succinylation of ovalbumin (sOVA) is effective in a mouse model of atopic dermatitis. An experimental model of AD was reproduced by epicutaneous sensitization with ovalbumin (OVA). ASIT was performed with subcutaneous (SC) administration of increasing doses of OVA or sOVA. The levels of anti-OVA antibodies, as well as cytokines, were detected by ELISA. Skin samples from patch areas were taken for histologic examination. ASIT with either OVA or sOVA resulted in a reduction of both the anti-OVA IgE level and the IgG1/IgG2a ratio. Moreover, ASIT with sOVA increased the IFN-γ level in supernatants after splenocyte stimulation with OVA. Histologic analysis of skin samples from the sites of allergen application showed that ASIT improved the histologic picture by decreasing allergic inflammation in comparison with untreated mice. These data suggest that ASIT with a succinylated allergen represents promising approach for the treatment of AD.https://doi.org/10.1371/journal.pone.0135070 |
| spellingShingle | Nadezda Shershakova Elena Bashkatova Alexander Babakhin Sergey Andreev Alexandra Nikonova Igor Shilovsky Oleg Kamyshnikov Andrey Buzuk Olga Elisyutina Elena Fedenko Musa Khaitov Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis. PLoS ONE |
| title | Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis. |
| title_full | Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis. |
| title_fullStr | Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis. |
| title_full_unstemmed | Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis. |
| title_short | Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis. |
| title_sort | allergen specific immunotherapy with monomeric allergoid in a mouse model of atopic dermatitis |
| url | https://doi.org/10.1371/journal.pone.0135070 |
| work_keys_str_mv | AT nadezdashershakova allergenspecificimmunotherapywithmonomericallergoidinamousemodelofatopicdermatitis AT elenabashkatova allergenspecificimmunotherapywithmonomericallergoidinamousemodelofatopicdermatitis AT alexanderbabakhin allergenspecificimmunotherapywithmonomericallergoidinamousemodelofatopicdermatitis AT sergeyandreev allergenspecificimmunotherapywithmonomericallergoidinamousemodelofatopicdermatitis AT alexandranikonova allergenspecificimmunotherapywithmonomericallergoidinamousemodelofatopicdermatitis AT igorshilovsky allergenspecificimmunotherapywithmonomericallergoidinamousemodelofatopicdermatitis AT olegkamyshnikov allergenspecificimmunotherapywithmonomericallergoidinamousemodelofatopicdermatitis AT andreybuzuk allergenspecificimmunotherapywithmonomericallergoidinamousemodelofatopicdermatitis AT olgaelisyutina allergenspecificimmunotherapywithmonomericallergoidinamousemodelofatopicdermatitis AT elenafedenko allergenspecificimmunotherapywithmonomericallergoidinamousemodelofatopicdermatitis AT musakhaitov allergenspecificimmunotherapywithmonomericallergoidinamousemodelofatopicdermatitis |